Scientific Program 2016

17th November

Opening ceremony

Jude Fitzgibbon (London, UK):
Genetic and epigenetic alterations of small B-cell lymphomas 

Csaba Bödör (Budapest, Hungary):
The genomic landscape of chronic lymphocytic leukemia

András Matolcsy (Budapest, Hungary):
Richter transformation of chronic lymphocytic leukaemia

Roland Jager (Vienna, Austria):
Pathogenesis of myeloproliferative neoplasms

Leonie Saft (Stockholm, Sweden):
Novel aspects of myelodysplastic syndromes

Péter Király (Budapest, Hungary):
Genetic predisposition to myeloid malignancies

Daniel Veres (Budapest, Hungary):
Artificial intelligence guided therapy design in oncohematology

17:00-
19:00

Poster session
2nd floor of the Department of Pathology and Experimental Cancer Research

Morning session: 
New trends in haematopoietic stem cell transplantation

09:00-
09:10

Tamás Masszi (Budapest, Hungary):
Introduction: Activity and history of Hungarian  haemopoietic stem cell transplantation

Robert Gale (USA):
Lessons on haemopoietic stem cell transplantation

Francesco Dazzi (London, UK):
Mesenchymal stromal cells, biology, production and clinical use in haematology

10:05-
10:25

Krisztián Németh  (Wisconsin, USA):
Mesenchymal stem cells and macrophages: old friends with new perspectives

10:30-
10:50

Eliane Gluckman (Paris, France):
Cord blood transplantation 

10:50-11:10

Coffee break

Zoltán Pós (Budapest, Hungary):
Lymphocyte homing in graft versus host disease

11:25-
11:35

János Sinkó (Budapest, Hungary):
Viral infections following stem cell transplantation

Gergely Kriván (Budapest, Hungary):
Virus specific T-cell treatment following stem cell transplantation

Tamás Masszi (Budapest, Hungary):
T-cell replete graft with post-transplant cyclophosphamide in haploidentical and mismatched VUD SCT

Jane Apperley (London, UK):
Cellular therapy –  What is the future?

Afternoon session: Multidisciplinarity in onco-hematology

Richard Clark (Liverpool, UK):
Optimal management and avoidance of adverse events of treatment in chronic myeloid leukemia

Péter Holló (Budapest, Hungary):
Cutaneous side effects of molecularly targeted treatments in oncohematology

Judit Demeter (Budapest, Hungary):
Experience with low dose vemurafenib treatment in hairy cell leukemia

Roch Houot (Rennes, France):
Why immunooncology in hematology?

Zsolt Nagy (Budapest, Hungary):
Myeloma bone disease: from bisphosphonates to inhibitors of RANK ligand and beyond